Miranda; Leslie P.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Miranda; Leslie P..The latest application filed is for "peptide pac1 antagonists".
Company Profile
9.25.32
- Miranda; Leslie P. - Thousand Oaks CA
- Miranda, Leslie P. - New South Wales AU
Patent Activity
| Patent | Date |
|---|---|
| Modified Fc molecules Grant 11,266,744 - Gegg , et al. March 8, 2 | 2022-03-08 |
| Peptide Pac1 Antagonists App 20210395313 - CHEN; Irwin ; et al. | 2021-12-23 |
| Apelin Polypeptides App 20210261619 - HOLDER; Jerry Ryan ; et al. | 2021-08-26 |
| Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (gipr) App 20210154318 - CHENG; Yuan ; et al. | 2021-05-27 |
| RNAi Constructs for Inhibiting ASGR1 Expression and Methods of Use Thereof App 20210108212 - OLLMANN; Michael ; et al. | 2021-04-15 |
| Apelin polypeptides Grant 10,941,182 - Holder , et al. March 9, 2 | 2021-03-09 |
| Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) Grant 10,905,772 - Cheng , et al. February 2, 2 | 2021-02-02 |
| RNAi constructs for inhibiting ASGR1 expression and methods of use thereof Grant 10,870,856 - Ollmann , et al. December 22, 2 | 2020-12-22 |
| RNAi Constructs for Inhibiting ASGR1 Expression and Methods of Use Thereof App 20190309306 - OLLMANN; Michael ; et al. | 2019-10-10 |
| Potent and selective inhibitors of Nav1.7 Grant 10,344,060 - Murray , et al. July 9, 2 | 2019-07-09 |
| MODIFIED Fc MOLECULES App 20190151463 - GEGG; Colin V. ; et al. | 2019-05-23 |
| Modified Fc molecules Grant 10,188,740 - Gegg , et al. Ja | 2019-01-29 |
| Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (gipr) App 20180311372 - CHENG; Yuan ; et al. | 2018-11-01 |
| Potent and selective inhibitors of NA.sub.V1.3 and NA.sub.V1.7 Grant 9,796,766 - Murray , et al. October 24, 2 | 2017-10-24 |
| Potent and selective inhibitors of NA.sub.V1.7 Grant 9,636,418 - Murray , et al. May 2, 2 | 2017-05-02 |
| Apelin Polypeptides App 20170107255 - HOLDER; Jerry Ryan ; et al. | 2017-04-20 |
| Potent And Selective Inhibitors Of Nav1.3 And Nav1.7 App 20160304570 - MURRAY; Justin K. ; et al. | 2016-10-20 |
| Potent and selective inhibitors of Na.sub.V1.3 and Na.sub.V1.7 Grant 9,340,590 - Murray , et al. May 17, 2 | 2016-05-17 |
| Apj Receptor Agonists And Uses Thereof App 20160067347 - HOLDER; Jerry Ryan ; et al. | 2016-03-10 |
| Potent And Selective Inhibitors Of Nav1.7 App 20160024159 - MURRAY; Justin K. ; et al. | 2016-01-28 |
| MODIFIED Fc MOLECULES App 20160000932 - GEGG; Colin V. ; et al. | 2016-01-07 |
| Modified Fc molecules Grant 9,114,175 - Gegg , et al. August 25, 2 | 2015-08-25 |
| Dipeptides to enhance yield and viability from cell cultures Grant 9,012,178 - Kang , et al. April 21, 2 | 2015-04-21 |
| Potent And Selective Inhibitors Of Nav1.7 App 20150023988 - MURRAY; Justin K. ; et al. | 2015-01-22 |
| Toxin peptide therapeutic agents Grant 8,907,071 - Sullivan , et al. December 9, 2 | 2014-12-09 |
| Potent And Selective Inhibitors Of Nav1.3 And Nav1.7 App 20140073577 - Murray; Justin K. ; et al. | 2014-03-13 |
| Glp-1 Compounds App 20130203659 - MIRANDA; Leslie P. ; et al. | 2013-08-08 |
| Dipeptides To Enhance Yield And Viability From Cell Cultures App 20130189737 - Kang; Sohye ; et al. | 2013-07-25 |
| SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 App 20120121591 - Sullivan; John K. ; et al. | 2012-05-17 |
| CGRP peptide antagonists and conjugates Grant 8,168,592 - Gegg, Jr. , et al. May 1, 2 | 2012-05-01 |
| Modified Fc Molecules App 20120009205 - GEGG; Colin V. ; et al. | 2012-01-12 |
| DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression Grant 8,043,829 - Sullivan , et al. October 25, 2 | 2011-10-25 |
| Modified Fc molecules Grant 8,008,453 - Gegg , et al. August 30, 2 | 2011-08-30 |
| Methods of using conjugated toxin peptide therapeutic agents Grant 7,910,102 - Sullivan , et al. March 22, 2 | 2011-03-22 |
| Toxin Peptide Therapeutic Agents App 20110045587 - SULLIVAN; JOHN K. ; et al. | 2011-02-24 |
| Toxin peptide therapeutic agents Grant 7,833,979 - Sullivan , et al. November 16, 2 | 2010-11-16 |
| DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression Grant 7,834,164 - Sullivan , et al. November 16, 2 | 2010-11-16 |
| Methods of using OSK1 peptide analogs Grant 7,825,093 - Sullivan , et al. November 2, 2 | 2010-11-02 |
| Conjugated toxin peptide therapeutic agents Grant 7,820,623 - Sullivan , et al. October 26, 2 | 2010-10-26 |
| OSK1 peptide analogs and pharmaceutical compositions Grant 7,803,769 - Sullivan , et al. September 28, 2 | 2010-09-28 |
| Methods of using OSK1 peptide analogs App 20090318341 - Sullivan; John K. ; et al. | 2009-12-24 |
| DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression App 20090305399 - Sullivan; John K. ; et al. | 2009-12-10 |
| Methods of using conjugated toxin peptide therapeutic agents App 20090297520 - Sullivan; John K. ; et al. | 2009-12-03 |
| DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression App 20090299044 - Sullivan; John K. ; et al. | 2009-12-03 |
| Conjugated toxin peptide therapeutic agents App 20090291885 - Sullivan; John K. ; et al. | 2009-11-26 |
| OSK1 peptide analogs and pharmaceutical compositions App 20090281028 - Sullivan; John K. ; et al. | 2009-11-12 |
| CGRP peptide antagonists and conjugates App 20080020978 - Gegg; Colin V. JR. ; et al. | 2008-01-24 |
| Modified Fc molecules App 20070269369 - Gegg; Colin V. ; et al. | 2007-11-22 |
| Toxin peptide therapeutic agents App 20070071764 - Sullivan; John K. ; et al. | 2007-03-29 |
| Matrix solid-phase organic synthesis App 20030144467 - Meldal, Morten ; et al. | 2003-07-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 